Oxbryta Archives -

Pfizer’s reported interest in acquiring sickle cell disease specialist Global Blood Therapeutics (GBT) has been confirmed, with the

Pfizer vaults into sickle cell market as GBT deal confirmed

https://pharmaphorum.com/news/pfizer-vaults-into-sickle-cell-market-as-gbt-deal-confirmed/

Pfizer is on the brink of announcing a deal to buy Global Blood Therapeutics (GBT) and its oral

Pfizer bid for sickle cell drug developer GBT said to be imminent

https://pharmaphorum.com/news/pfizer-bid-for-sickle-cell-drug-developer-gbt-said-to-be-imminent/

Global Blood Therapeutics’ run of positive regulatory news for its oral sickle cell disease treatment Oxbryta has continued

GBT claims EU approval for sickle cell drug Oxbryta

https://pharmaphorum.com/news/gbt-claims-eu-approval-for-sickle-cell-drug-oxbryta/

Oxbryta